Kim, Bo Ram
Yoo, Tae Keun https://orcid.org/0000-0003-0890-8614
Kim, Hong Kyu
Ryu, Ik Hee
Kim, Jin Kuk
Lee, In Sik
Kim, Jung Soo
Shin, Dong-Hyeok
Kim, Young-Sang
Kim, Bom Taeck https://orcid.org/0000-0002-0395-0410
Article History
Received: 20 June 2022
Accepted: 25 July 2022
First Online: 8 August 2022
Declarations
:
: The study protocol was approved by the Institutional Review Board of the Korean Center for Disease Control and Prevention (No. 2008–04EXP-01-C, 2009–01CON-03-C, 2010–02CON-21-C, and 2011–02CON-06-C). The raw data sets are publicly available through the KNHANES website, and data collection from the KNHANES dataset was approved by the Institutional Review Board of the Korean National Institute for Bioethics Policy, which waived the requirement for informed consent for this study. The study adhered to the tenets of the Declaration of Helsinki.
: Not applicable.
: Jin Kuk Kim, Ik Hee Ryu, and Tae Keun Yoo are executives of VISUWORKS, Inc., a Korean artificial intelligence company providing medical machine learning solutions. Jin Kuk Kim is an executive of the Korea Intelligent Medical Industry Association. They received salaries or stocks as part of their standard compensation packages. The remaining authors declare no conflicts of interest.